The biotech market sold off last week, with the Nasdaq Biotechnology Index dropping 4.5% since April 23. That means some of the best biotech stocks have dipped as well.
Now, investors are wondering if they should take their money to the sideline. But Money Morning's Bioscience Investing Specialist Ernie Tremblay says this type of move is normal for the biotech market.
"The sell-off we're seeing now seems to happen every year at about
this time, like clockwork," Tremblay said on March 27. "There are always
things going on in the news that seem to explain the drop, but the
meta-picture is simply this: The market breathes in, and the market
breathes out." (more)
Please share this article
No comments:
Post a Comment